General Updates

October 08, 2026 BSE Limited National Stock Exchange of India Phiroze Jeejeebhoy Towers, Limited Dalal Street, Exchange Plaza, Plot no. C/1, G Block, Mumbai- 400 001 Bandra-Kurla Complex Scrip Code: 543434 Bandra (E), Mumbai - 400 051 NSE Symbol: SUPRIYA Dear Sir/Madam, Subject: Further Update on Judicial Proceedings – Intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 Dear Sir/Madam, In furtherance to the earlier intimation made by the Company to the Stock Exchanges dated September 23, 2026, regarding the order received from the Hon’ble High Court in the matter, the Company hereby informs that it has filed an petition before the Hon’ble Supreme Court of India in connection with the said matter today i.e October 8, 2026. The matter is presently sub judice and is pending consideration before the Hon’ble Court. Accordingly, at this stage, the Company does not wish to comment further on the merits or outcome of the proceedings. The Company shall continue to closely monitor the matter and will keep the Stock Exchanges and the shareholders informed of any material developments and further updates, as and when received from the Hon’ble Court or otherwise in accordance with applicable laws and regulations. This is for your information and records. Thanking you, For Supriya Lifescience Limited Prachi Sathe Company Secretary & Compliance Officer Corporate office : 207/208, Udyog Bhavan, Sonawala Road, Goregaon (East), Mumbai – 400 063. Maharashtra, India. Tel: +91 22 40332727 / 66942507 Fax : +91 22 26860011 GSTIN: 27AALCS8686A1ZX CIN: L51900MH2008PLC180452 E-mail: supriya@supriyalifescience .com Website: www.supriyalifescience.com Factory : A-5/2, Lote Parshuram Industrial Area, M.I.D.C. Tal.– Khed, Dist. – Ratnagiri, Pin :415 722, Maharashtra, India. Tel: +91 2356 272299 Fax: +91 2356 272178 E-mail: factory@supriyalifescience.com GOVT. RECOGNISED EXPORT HOUSE